OLANDER CLINICAL CONSULTING K/S: Financial statements 2020
CVR: 35860177
OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,535,704 and a net result of DKK 1,501,968 compared with DKK 1,407,595 the year before. That is an increase of 6.9% compared with the year before. Equity amounted to DKK 461,017. The solvency ratio was 49.2%.
- Gross Profit
- 1,535,704 kr.
- Profit/Loss
- 1,501,968 kr.
- Equity
- 461,017 kr.
- Total Assets
- 937,566 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1.5 mio. | 1.5 mio. | 461 t. | - |
| 2019 | - | 1.4 mio. | 1.4 mio. | 491 t. | - |
| 2018 | - | 1.7 mio. | 1.7 mio. | 700 t. | - |
| 2017 | - | 1.3 mio. | 1.3 mio. | 518 t. | - |
| 2016 | - | 1.5 mio. | 1.5 mio. | 699 t. | - |
How creditworthy is OLANDER CLINICAL CONSULTING K/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
OLANDER CLINICAL CONSULTING K/S has published its annual report for 2019. Gross profit came to DKK 1,436,888, and the net result was DKK 1,407,595.
About OLANDER CLINICAL CONSULTING K/S
OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.
